Henlius Wins Chinese Approval For Rituximab RA Indication

Wider Potential Patient Population Allows Firm ‘Differentiated Strategy’

 
• By Dave Wallace
  
China Flag Thumbs Up
China’s NMPA has approved the Rituxan rival’s RA indication • Source: Micha Klootwijk / Alamy Stock Photo

More from Biosimilars

More from Products